Literature DB >> 11008175

Contributions of mGlu1 and mGlu5 receptors to interactions with N-methyl-D-aspartate receptor-mediated responses and nociceptive sensory responses of rat thalamic neurons.

T E Salt1, K E Binns.   

Abstract

The nociceptive responses of rat ventrobasal thalamus neurons can be reduced by N-methyl-D-aspartate antagonists and by selective metabotropic glutamate receptor mGlu1 antagonists. The recent development of the mGlu5-selective antagonist 6-methyl-2-(phenylethynyl)-pyridine now allows the direct probing of the possible involvement of mGlu5 receptors in thalamic nociceptive responses. Extracellular recordings were made from single neurons in the ventrobasal thalamus and immediately overlying dorsal thalamic nuclei of adult urethane-anaesthetized rats using multi-barrel electrodes. Responses of neurons to iontophoretic applications of the mGlu5-selective agonist (R,S)-2-chloro-5-hydroxyphenylglycine were selectively reduced during continuous iontophoretic applications of 6-methyl-2-(phenylethynyl)-pyridine. Similar applications of 6-methyl-2-(phenylethynyl)-pyridine reduced neuronal responses to noxious thermal stimuli to 53+/-9.5% of control responses. Co- application by iontophoresis of N-methyl-D-aspartate and metabotropic glutamate receptor agonists resulted in a mutual potentiation of excitatory responses. This effect could be reduced by either 6-methyl-2-(phenylethynyl)-pyridine or the mGlu1 antagonist LY367385. These results, taken together with previous data, suggest that acute thalamic nociceptive responses are mediated by a combination of mGlu1, mGlu5 and N-methyl-D-aspartate receptor activation, and that co-activation of these receptors produces a synergistic excitatory effect. Thus blockade of any of these receptor types would have a profound effect on the overall nociceptive response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11008175     DOI: 10.1016/s0306-4522(00)00265-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  17 in total

1.  Interactions between adenosine and metabotropic glutamate receptors in the rat hippocampal slice.

Authors:  Ali Shahraki; Trevor W Stone
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

2.  Metabotropic glutamate and cannabinoid receptor crosstalk in periaqueductal grey pain processing.

Authors:  E Palazzos; V de Novellis; I Marabese; F Rossi; S Maione
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

Review 3.  Glutamate receptor functions in sensory relay in the thalamus.

Authors:  T E Salt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-12-29       Impact factor: 6.237

4.  Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij rats.

Authors:  V D'Amore; I Santolini; C M van Rijn; F Biagioni; G Molinaro; A Prete; P J Conn; C W Lindsley; Y Zhou; P N Vinson; A L Rodriguez; C K Jones; S R Stauffer; F Nicoletti; G van Luijtelaar; R T Ngomba
Journal:  Neuropharmacology       Date:  2012-06-15       Impact factor: 5.250

Review 5.  Glutamate and Its Receptors as Therapeutic Targets for Migraine.

Authors:  Jan Hoffmann; Andrew Charles
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

6.  Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5.

Authors:  Carmela M Reichel; Marek Schwendt; Jacqueline F McGinty; M Foster Olive; Ronald E See
Journal:  Neuropsychopharmacology       Date:  2010-12-08       Impact factor: 7.853

7.  Interaction of group I mGlu and NMDA receptor agonists within the dorsal horn of the spinal cord of the juvenile rat.

Authors:  K Dang; S Naeem; K Walker; N G Bowery; L Urban
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

8.  The group I metabotropic glutamate receptor mGluR5 is required for fear memory formation and long-term potentiation in the lateral amygdala.

Authors:  Sarina M Rodrigues; Elizabeth P Bauer; Claudia R Farb; Glenn E Schafe; Joseph E LeDoux
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

9.  Gi protein functions in thalamic neurons to decrease orofacial nociceptive response.

Authors:  Jennifer Strand; Crystal Stinson; Larry L Bellinger; Yuan Peng; Phillip R Kramer
Journal:  Brain Res       Date:  2018-05-12       Impact factor: 3.252

10.  Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism.

Authors:  Nathalie Breysse; Christelle Baunez; Will Spooren; Fabrizio Gasparini; Marianne Amalric
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.